The Indian Pharmaceutical Alliance (IPA) was established in the year 1999 in Mumbai. IPA represents research-based National Pharmaceutical Companies in India. The IPA works closely with the Government on policy related matters and seeks to imbibe the experiences of the generic pharmaceutical industry internationally. It is also partnering with the Government in the evolution of a patent regime and upgradation of the regulatory regime in India. Collectively, IPA member companies account for over 85 per cent of the private sector investment in pharmaceutical Research & Development. They also contribute to more than 80 per cent of the country's exports of drugs & pharmaceuticals. Mission: 1. To make quality medicines available, accessible and affordable to people across the world 2. To disseminate knowledge, share best practices and work towards excellence in quality 3. To contribute to policy dialogues on these topics Community Guidelines: https://bit.ly/IPAcommunityguidelines
View Top Employees from Indian Pharmaceutical AllianceWebsite | https://www.ipa-india.org/ |
Revenue | $22.3 million |
Employees | 25 (14 on RocketReach) |
Founded | 1999 |
Address | Landmark 1:, A-205 Sangam, 14B, SV Rd, opp. Vijay Sales Showroom, Santacruz West, Mumbai, Maharashtra 400054, IN |
Phone | +91 22 2610 9281 |
Technologies |
JavaScript,
HTML,
PHP
+19 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Indian Pharmaceutical Alliance employee's phone or email?
The Indian Pharmaceutical Alliance annual revenue was $22.3 million in 2024.
14 people are employed at Indian Pharmaceutical Alliance.
Indian Pharmaceutical Alliance is based in Mumbai, Maharashtra.
The NAICS codes for Indian Pharmaceutical Alliance are [32, 325, 32541, 3254].
The SIC codes for Indian Pharmaceutical Alliance are [28, 283].